ProMIS Neurosciences, Inc.
PMN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $10 | $9 | $5 | $4 |
| G&A Expenses | $0 | $1 | $2 | $0 |
| SG&A Expenses | $2 | $1 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $12 | $10 | $7 | $6 |
| Operating Income | -$12 | -$10 | -$7 | -$6 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $0 | $0 | $6 |
| Pre-Tax Income | -$12 | -$10 | -$7 | -$0 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$12 | -$10 | -$7 | -$0 |
| % Margin | – | – | – | – |
| EPS | -6 | -7.25 | -5.25 | -0.245 |
| % Growth | 17.2% | -38.1% | -2,042.9% | – |
| EPS Diluted | -6 | -7.25 | -5.25 | -0.245 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$12 | -$10 | -$7 | -$0 |
| % Margin | – | – | – | – |